Matrix Capital Management Company, LP - Dec 31, 2024 Form SCHEDULE 13G/A Schedule Report for Adaptimmune Therapeutics plc (ADAP)

Filing Manager: Matrix Capital Management Company, LP
Reporting Manager: Matrix Capital Management Company LP
Security: Adaptimmune Therapeutics plc Ordinary Shares, par value 0.001 GBP per share
Symbol: ADAP
Disclosed Ownership: 0 shares
Ownership: 0%
Form type: SCHEDULE 13G/A
Date filed: 1/8/2025, 10:30 AM
Date of event: Dec 31, 2024
Previous filing: Dec 5, 2024
SEC: View on sec.gov

Reporting Managers (2)

Name	Ownership	Shares Owned	sole voting power	shared voting power	Signature	Title	CIK
Matrix Capital Management Company LP	0%	0	0	0	/s/ David E. Goel	David E. Goel, Managing General Partner
David E. Goel	0%	0	0	0	/s/ David E. Goel	David E. Goel, individually